Chronic Obstructive Pulmonary Disease (COPD) and asthma are among the most prevalent respiratory diseases globally, affecting millions of individuals and placing a substantial burden on healthcare systems. Accurate diagnosis and effective monitoring are crucial for managing these conditions and improving patient outcomes. The market for COPD and asthma diagnostic and monitoring devices is expanding rapidly, driven by technological advancements, rising prevalence of respiratory diseases, and increasing awareness about early diagnosis and management.